Beware, vaping can be as bad as cigarettes, as it can cause the similar deadly lung diseases, warns a study.
According to researchers, e-cigarettes appear to trigger unique immune responses which cigarettes also trigger, according to a new research.
Senior study author Mehmet Kesimer from the University of North Carolina Chapel Hill and co-authors report findings from what they believe is the first study to use human airway samples to explore the harmful effects of e-cigarettes.
"There is confusion about whether e-cigarettes are 'safer' than cigarettes because the potential adverse effects of e-cigarettes are only beginning to be studied," Dr Kesimer stated.
A 2016 Surgeon General's report found that e-cigarette use increased by 900 percent among high school students from 2011 to 2015.
Also in 2016, the Food and Drug Administration extended its regulatory oversight of tobacco products to include e-cigarettes.
The study compared sputum samples from 15 e-cigarette users, 14 current cigarette smokers and 15 non-smokers.
They found e-cigarette users uniquely exhibited significant increases in:
Neutrophil granulocyte and neutrophil-extracellular-trap (NET) related proteins in their airways.
Although neutrophils are important in fighting pathogens, left unchecked neutrophils can contribute to inflammatory lung diseases, such as COPD and cystic fibrosis.
NETs are associated with cell death in the epithelial and endothelium, the tissues lining blood vessels and organs.
The authors wrote that more research is necessary to determine if this increase is associated with systemic inflammatory diseases, such as lupus, vasculitis, and psoriasis.
The study also found that e-cigarettes produced some of the same negative consequences as cigarettes.
Both e-cigarette and cigarette users exhibited significant increases in:
Biomarkers of oxidative stress and activation of innate defense mechanisms associated with lung disease. Among these biomarkers are aldehyde-detoxification and oxidative-stress-related proteins, thioredoxin (TXN), and matrix metalloproteinase-9 (MMP9).
The data showed that e-cigarettes have a signature of harm in the lung that is both similar and unique, which challenges the concept that switching from cigarettes to e-cigarettes is a healthier alternative.
The study appears in online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
